Tin tức & Cập nhật
Lọc theo Chuyên ngành:
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
13 Nov 2024
Prompt DOAC therapy after stroke safe for AF patients
Initiating direct oral anticoagulants (DOACs) within 4 days after an ischaemic stroke in patients with atrial fibrillation (AF) is safe and yields similar outcomes as delayed initiation, as shown in the phase 4 OPTIMAS trial.
Prompt DOAC therapy after stroke safe for AF patients
11 Nov 2024
Elagolix on par with dienogest for endometriosis-related pain
In the treatment of pain due to endometriosis, use of elagolix 150-mg tablets demonstrates comparable efficacy to dienogest 2-mg tablets, as assessed via numeric rating scale (NRS) score from baseline to day 85 and 169, according to a study presented at RCOG 2024. Additionally, both drugs are well tolerated.
